About Transgene Biotek Ltd
Transgene Biotek is an Indian public biotech firm, established in 1990, focused on R&D for vaccines, oncology, biogenerics, and novel drug delivery (oral/nasal proteins/peptides) for unmet needs, exporting to various global markets and developing treatments for cancer, auto-immune issues, etc
Founded
1990
CEO
K Koteswara Rao
Employees
0
HQ
Sangareddy, Telangana
Finished Products
1Sales
₹0.55CrRaw Materials
1RM Consumed
₹0.00CrAbout Transgene Biotek Ltd
Transgene Biotek is an Indian public biotech firm, established in 1990, focused on R&D for vaccines, oncology, biogenerics, and novel drug delivery (oral/nasal proteins/peptides) for unmet needs, exporting to various global markets and developing treatments for cancer, auto-immune issues, etc
Founded:1990
CEO:K Koteswara Rao
Employees:0
HQ:Sangareddy, Telangana
Finished Products
1Sales
₹0.55CrRaw Materials
1RM Consumed
₹0.00CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹5
52W Low
₹2
Volume34.59K
Avg VolumeN/A
Beta1.13
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
-12.86x
Valuation
P/B Ratio
2.44x
Valuation
EPS
₹-0.21
Valuation
Dividend Yield
0.00%
Valuation
ROE
-19.73%
Profitability
ROCE
-2.32%
Profitability
Revenue by Segment
Contribution & growth by business line
Diagnostic Services
-41.9%100.0%
₹0.18 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
2.05x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
63.0%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.